Literature DB >> 28755079

Pancreatic adenocarcinoma with a germline PTEN p.Arg234Gln mutation.

Sunao Uemura1,2, Hiroyuki Matsubayashi3,4, Yoshimi Kiyozumi5, Katsuhiko Uesaka2, Yusuke Yamamoto2, Keiko Sasaki1, Masato Abe1, Kenichi Urakami6, Masatoshi Kusuhara6, Ken Yamaguchi6.   

Abstract

A minor fraction of pancreatic ductal adenocarcinoma (PDAC) develops in association with germline mutations of the genes responsible for inherited cancer syndromes. However, the PDAC that has a germline PTEN mutation has not received much attention. Genome-wide whole exome sequencing was performed on germline and somatic DNA from an 82-year-old woman who had developed a solid pancreatic cancer but did not show characteristic findings of PTEN hamartoma tumor syndromes (PHTS). Histology of the resected pancreatic tumor showed unique PDAC findings of primarily dendriform structures and dense fibrous tissue, accompanied by multiple pancreatic intraepithelial neoplasias in the vicinity. The tumor immunohistochemistry revealed a loss of PTEN expression and overexpression of TP53. Exome sequencing revealed a K-ras mutation (p.Gly12Val). Germline exome sequencing revealed a missense mutation of PTEN (p.Arg234Gln), a rare variant with a reported association with cancer development but not with other PHTS phenotypes. To our knowledge, this is the first report of PDAC associated with a germline PTEN mutation, particularly a rare variant (p.Arg234Gln) with cancer risks.

Entities:  

Keywords:  Adenocarcinoma; Germline mutation; PTEN; Pancreas; p.Arg234Gln (R234Q)

Mesh:

Substances:

Year:  2018        PMID: 28755079     DOI: 10.1007/s10689-017-0025-7

Source DB:  PubMed          Journal:  Fam Cancer        ISSN: 1389-9600            Impact factor:   2.375


  9 in total

1.  Next generation sequencing approach for detecting 491 fusion genes from human cancer.

Authors:  Kenichi Urakami; Yuji Shimoda; Keiichi Ohshima; Takeshi Nagashima; Masakuni Serizawa; Tomoe Tanabe; Junko Saito; Tamiko Usui; Yuko Watanabe; Akane Naruoka; Sumiko Ohnami; Shumpei Ohnami; Tohru Mochizuki; Masatoshi Kusuhara; Ken Yamaguchi
Journal:  Biomed Res       Date:  2016       Impact factor: 1.203

2.  PTEN is a major tumor suppressor in pancreatic ductal adenocarcinoma and regulates an NF-κB-cytokine network.

Authors:  Haoqiang Ying; Kutlu G Elpek; Anant Vinjamoori; Stephanie M Zimmerman; Gerald C Chu; Haiyan Yan; Eliot Fletcher-Sananikone; Hailei Zhang; Yingchun Liu; Wei Wang; Xiaojia Ren; Hongwu Zheng; Alec C Kimmelman; Ji-hye Paik; Carol Lim; Samuel R Perry; Shan Jiang; Brian Malinn; Alexei Protopopov; Simona Colla; Yonghong Xiao; Aram F Hezel; Nabeel Bardeesy; Shannon J Turley; Y Alan Wang; Lynda Chin; Sarah P Thayer; Ronald A DePinho
Journal:  Cancer Discov       Date:  2011-05-23       Impact factor: 39.397

3.  Tumor-infiltrating lymphocytes are a marker for microsatellite instability in colorectal carcinoma.

Authors:  T C Smyrk; P Watson; K Kaul; H T Lynch
Journal:  Cancer       Date:  2001-06-15       Impact factor: 6.860

Review 4.  Familial thyroid cancer: a review.

Authors:  Vânia Nosé
Journal:  Mod Pathol       Date:  2011-04       Impact factor: 7.842

5.  Allelic imbalance, including deletion of PTEN/MMACI, at the Cowden disease locus on 10q22-23, in hamartomas from patients with Cowden syndrome and germline PTEN mutation.

Authors:  D J Marsh; P L Dahia; V Coulon; Z Zheng; F Dorion-Bonnet; K M Call; R Little; A Y Lin; R A Eeles; A M Goldstein; S V Hodgson; A L Richardson; B G Robinson; H C Weber; M Longy; C Eng
Journal:  Genes Chromosomes Cancer       Date:  1998-01       Impact factor: 5.006

6.  Tenets of PTEN tumor suppression.

Authors:  Leonardo Salmena; Arkaitz Carracedo; Pier Paolo Pandolfi
Journal:  Cell       Date:  2008-05-02       Impact factor: 41.582

7.  Functionally distinct groups of inherited PTEN mutations in autism and tumour syndromes.

Authors:  Laura Spinelli; Fiona M Black; Jonathan N Berg; Britta J Eickholt; Nicholas R Leslie
Journal:  J Med Genet       Date:  2014-12-19       Impact factor: 6.318

8.  A novel germline mutation of PTEN associated with brain tumours of multiple lineages.

Authors:  F J T Staal; R B van der Luijt; M R M Baert; J van Drunen; H van Bakel; E Peters; I de Valk; H K P van Amstel; M J B Taphoorn; G H Jansen; C W M van Veelen; B Burgering; G E J Staal
Journal:  Br J Cancer       Date:  2002-05-20       Impact factor: 7.640

9.  Noncatalytic PTEN missense mutation predisposes to organ-selective cancer development in vivo.

Authors:  Enrico Caserta; Onur Egriboz; Hui Wang; Chelsea Martin; Christopher Koivisto; Thierry Pecót; Raleigh D Kladney; Changxian Shen; Kang-Sup Shim; Thac Pham; Matthew K Karikomi; Melissa J Mauntel; Sarmila Majumder; Maria C Cuitino; Xing Tang; Arunima Srivastava; Lianbo Yu; Julie Wallace; Xiaokui Mo; Morag Park; Soledad A Fernandez; Robert Pilarski; Krista M D La Perle; Thomas J Rosol; Vincenzo Coppola; Diego H Castrillon; Cynthia Timmers; David E Cohn; David M O'Malley; Floor Backes; Adrian A Suarez; Paul Goodfellow; Helen M Chamberlin; Erin R Macrae; Charles L Shapiro; Michael C Ostrowski; Gustavo Leone
Journal:  Genes Dev       Date:  2015-08-15       Impact factor: 11.361

  9 in total
  4 in total

Review 1.  Surveillance of Individuals with a Family History of Pancreatic Cancer and Inherited Cancer Syndromes: A Strategy for Detecting Early Pancreatic Cancers.

Authors:  Hiroyuki Matsubayashi; Yoshimi Kiyozumi; Hirotoshi Ishiwatari; Katsuhiko Uesaka; Masataka Kikuyama; Hiroyuki Ono
Journal:  Diagnostics (Basel)       Date:  2019-10-31

2.  PTEN suppresses the inflammation, viability, and motility of AP-AR42J cells by activating the Wnt/β-catenin pathway.

Authors:  Hongtao Yan; Li Jiang; Hong Zou; Tao Chen; Hongyin Liang; Lijun Tang
Journal:  RSC Adv       Date:  2019-02-13       Impact factor: 3.361

3.  A comprehensive analysis of candidate genes in familial pancreatic cancer families reveals a high frequency of potentially pathogenic germline variants.

Authors:  Julie Earl; Cristina Galindo-Pumariño; Jessica Encinas; Emma Barreto; Maria E Castillo; Vanessa Pachón; Reyes Ferreiro; Mercedes Rodríguez-Garrote; Silvia González-Martínez; Teresa Ramon Y Cajal; Luis Robles Diaz; Isabel Chirivella-Gonzalez; Montse Rodriguez; Eva Martínez de Castro; David García-Seisdedos; Gloria Muñoz; Juan Manuel Rosa Rosa; Mirari Marquez; Nuría Malats; Alfredo Carrato
Journal:  EBioMedicine       Date:  2020-02-27       Impact factor: 8.143

4.  Metachronous ovarian endometrioid carcinomas in a patient with a PTEN variant: case report of incidentally detected Cowden syndrome.

Authors:  Hiroyuki Matsubayashi; Satomi Higashigawa; Yoshimi Kiyozumi; Yasue Horiuchi; Yasuyuki Hirashima; Nobuhiro Kado; Masato Abe; Takuma Ohishi; Sumiko Ohnami; Kenichi Urakami; Ken Yamaguchi
Journal:  BMC Cancer       Date:  2019-10-29       Impact factor: 4.430

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.